CMC Financial Group Acquires Shares of 365 Axon Enterprise, Inc. (NASDAQ:AXON)

CMC Financial Group acquired a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) during the 4th quarter, Holdings Channel.com reports. The fund acquired 365 shares of the biotechnology company’s stock, valued at approximately $217,000. Axon Enterprise makes up approximately 0.5% of CMC Financial Group’s investment portfolio, making the stock its 29th biggest position.

Several other institutional investors and hedge funds have also recently bought and sold shares of AXON. Prestige Wealth Management Group LLC raised its stake in Axon Enterprise by 115.8% during the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after buying an additional 44 shares in the last quarter. New Wave Wealth Advisors LLC acquired a new stake in Axon Enterprise during the fourth quarter valued at approximately $40,000. Brooklyn Investment Group acquired a new stake in Axon Enterprise during the third quarter valued at approximately $41,000. Y.D. More Investments Ltd acquired a new stake in Axon Enterprise during the fourth quarter valued at approximately $45,000. Finally, Stonebridge Financial Group LLC acquired a new stake in Axon Enterprise during the fourth quarter valued at approximately $53,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the company. Craig Hallum cut Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. The Goldman Sachs Group increased their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. TD Cowen assumed coverage on Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target on the stock. Finally, Northcoast Research cut Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. One research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $604.67.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON opened at $560.00 on Monday. The stock has a fifty day moving average price of $591.90 and a two-hundred day moving average price of $543.57. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The firm has a market cap of $42.91 billion, a P/E ratio of 144.70, a PEG ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a 1 year low of $273.52 and a 1 year high of $715.99.

Insider Buying and Selling at Axon Enterprise

In other news, Director Jeri Williams sold 307 shares of the firm’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the sale, the director now directly owns 1,627 shares of the company’s stock, valued at $899,275.44. This trade represents a 15.87 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by corporate insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.